Potential Antimicrobial Strategy Using Genetically Engineered Homo & Hetero-Dimer of alpha-Lactalbumin and Lysozyme
Potential Antimicrobial Strategy Using Genetically Engineered Homo & Hetero-Dimer of alpha-Lactalbumin and Lysozyme
批准号:
13660129
负责人:
IBRAHIM Hisham r.
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mammalian milk is characterized by a complex host defense system that prevents the growth of microbial pathogens that may pervade the infant. However, little is known of the fate of the antimicrobial components and precisely how they interact to protect the recipient. Alpha-lactalbumin (α-LA) is one of the major proteins in milk of all species and has the unusual property of acting to modify the action of galactosyltransferase to a lactose synthase. On the other hand, lysozyme (LZ), a homologous protein to α-LA, is a ubiquitous antimicrobial in a variety of tissues and secretions. These two proteins uniquely co-exist in mammalian milk but the significance of their distinct presence in milk is completely unknown. In this study, LZ and α-LA were investigated to elucidate the nature of their interaction and antibacterial synergy. A complex of LZ and α-LA exhibited greatly enhanced antibacterial activity against the Gram-positive and -negative bacteria. Under physiological pH, α-LA associa … More ted with LZ, whereas the complex existed mainly as LZ-αLA heterodimer with LZ homodimer. The results provided the first demonstration of association of α-LA with LZ leading to the formation of a distinct complex with significantly enhanced bactericidal activity. Our results strongly suggest the important role of LZ and α-LA in the host defense system of the newborn against gastric microbial infections. Furthermore, a parallel genetic study was initiated with the objectives of cloning the cDNAs of human LZ (hLZ) and human LA (hLA) from human mammary epithelial cells, establish high-level expression system in Pichia under the native signal peptides of the two human proteins, and to design a stable in-frame fusion constructs between hLZ and hLA., Human LZ, α-LA, and their LZ-α-LA fusion construct were successfully produced in Pichia methanolica with expression level exceeding 20 mg/L and thus offer a great opportunity for the design of potential antimicrobial drug in the treatment of infectious diseases. Less
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.R.IBRAHIM, U.Thomas, A.Pellegrini: "A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action"Journal of Biological Chemistry. 276(47). 43767-43774 (2001)
H.R.IBRAHIM、U.Thomas、A.Pellegrini:“溶菌酶活性位点裂缝上唇处的螺旋-环-螺旋肽赋予有效的抗菌活性和膜透化作用”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
R.IBRAHIM, T.Aoki: "New Promises of Lysozyme as Immune Modulator and Antimicrobial Agent for Nutraceuticals"Foods & Food Ingredients Journal. 208(5). 361-374 (2003)
R.IBRAHIM、T.Aoki:“溶菌酶作为营养保健品的免疫调节剂和抗菌剂的新前景”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.R.IBRAHIM, T.Matsuzaki, T.Aoki: "Genetic evidence that antibacterial activity of lysozyme is independent of its catalytic function."FEBS Letters. 506. 27-32 (2001)
H.R.IBRAHIM、T.Matsuzaki、T.Aoki:“溶菌酶的抗菌活性与其催化功能无关的遗传证据。”FEBS 快报。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.R.IBRAHIM, T.Aoki: "New Promises of Lysozyme as Immune Modulator and Antimicrobial Agent for Nutraceuticals"Journal of Foods & Food Ingredients. (In Press).
H.R.IBRAHIM、T.Aoki:“溶菌酶作为营养保健品免疫调节剂和抗菌剂的新前景”食品杂志
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.R.IBRAHIM, U.Thomas, A.Pellegrini: "A helix-loop-helix peptide at the upper lip of the active site cleft of Lysozyme confers potent antimicrobial activity with membrane permeabilization action."Journal of Biological Chemistry. 276(47). 43767-43774 (2001
H.R.IBRAHIM、U.Thomas、A.Pellegrini:“溶菌酶活性位点裂缝上唇处的螺旋-环-螺旋肽赋予了有效的抗菌活性和膜透化作用。”生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
海外基金